Centene Operating Cash Flow increased by 899.1% to $4.37B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 189.1%, from $1.51B to $4.37B. Over 2 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 10.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.69B | $1.80B | $675.00M | $1.15B | $3.35B | $3.33B | $4.27B | $2.55B | $1.02B | $217.00M | -$456.00M | $2.18B | -$978.00M | $1.51B | $1.79B | $1.36B | $437.00M | $4.37B |
| QoQ Change | — | +6.9% | -62.5% | +70.5% | +191.4% | -0.7% | +28.1% | -40.4% | -59.9% | -78.7% | -310.1% | +577.0% | -145.0% | +254.4% | +18.2% | -24.0% | -67.8% | +899.1% |
| YoY Change | — | — | — | — | +99.1% | +84.9% | +270.9% | -24.1% | -69.4% | — | -110.7% | -14.6% | -195.8% | +431.1% | -17.9% | +238.7% | — | +189.1% |